16:11 EST Prelude Therapeutics (PRLD) files to sell 6.25M shares of common stock for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRLD:
- Prelude Therapeutics presents data at 2025 ASH meeting from MPN programs
- Prelude Therapeutics’ Earnings Call Highlights Strategic Moves and Challenges
- Prelude Therapeutics Advances Pipeline and Strengthens Financials
- Prelude Therapeutics Reports Q3 2025 Financial Results
- Prelude Therapeutics reports Q3 EPS (26c) vs. (43c) last year